TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Palmegren FysMed Consult AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
143
|
144 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
27
|
29 | |
| EBITDA |
29
|
30 | |
| Total assets |
74
|
69 | |
| Current assets |
70
|
59 | |
| Current liabilities |
22
|
21 | |
| Equity capital |
46
|
42 | |
| - share capital |
4
|
5 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
62.2%
|
60.9% | |
| Turnover per employee |
143
|
144 | |
| Profit as a percentage of turnover |
18.9%
|
20.1% | |
| Return on assets (ROA) |
36.5%
|
42.0% | |
| Current ratio |
318.2%
|
281.0% | |
| Return on equity (ROE) |
58.7%
|
69.0% | |
| Change turnover |
4
|
13 | |
| Change turnover % |
-8%
|
3%
|
10% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.